News

Public · Published

ORCL Inches Higher After Pricing $20B Equity And Bond Offering: New Shares Priced At Discount To Last Close And 50-Day Average

Oracle priced a $20 billion equity and bond offering, selling 86.2 million shares at $116, below Monday's $119.20 close and the $141.25 50-day average. Net stock proceeds are about $9.9 billion and note proceeds about $10 billion, both closing November 4.

Published:

Updated:

What happened

Oracle priced a $20 billion equity and bond offering, selling 86.2 million shares at $116, below Monday's $119.20 close and the $141.25 50-day average. Net stock proceeds are about $9.9 billion and note proceeds about $10 billion, both closing November 4.

Confirmed

Global impact / market context

Selling new shares below the recent market price spreads ownership across more shares, which can lower profit per share for existing holders. Borrowed money at 7% to 8.65% adds interest costs, so Oracle must earn more from spending on equipment and acquisitions to justify the deal.

Analyst inference

The stock fell 8.6% Monday after the offering was first announced, then inched 0.2% overnight once pricing details arrived. The discount and high note yields suggest investors demanded compensation for new supply and debt, while Oracle's pledge to cap new AI financing at $20 billion through fiscal 2030 limits further raises.

Analyst inference

What to watch

  1. The shares and notes offerings close on November 4, so watch settlement and the final share count, which will show how much ownership was diluted beyond the 86.2 million shares priced. Confirmed
  2. Because Oracle said proceeds may fund capital expenditures, debt repayment, investments, acquisitions, dividends or buybacks, watch the next filing for the chosen use, since equipment spending differs from paying down borrowed money. Proposed
  3. Watch whether the stock holds near the $116 offering price, because trading below it would leave buyers of the new shares at a loss and could pressure Oracle's future fundraising plans. Analyst inference

Evidence